BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28205401)

  • 1. Computer-aided drug design to explore cyclodextrin therapeutics and biomedical applications.
    Abdolmaleki A; Ghasemi F; Ghasemi JB
    Chem Biol Drug Des; 2017 Feb; 89(2):257-268. PubMed ID: 28205401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-Aided Discovery of New Solubility-Enhancing Drug Delivery System.
    Mizera M; Muratov EN; Alves VM; Tropsha A; Cielecka-Piontek J
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32560246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The exploration of macrocycles for drug discovery--an underexploited structural class.
    Driggers EM; Hale SP; Lee J; Terrett NK
    Nat Rev Drug Discov; 2008 Jul; 7(7):608-24. PubMed ID: 18591981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel water-soluble fisetin/cyclodextrins inclusion complexes: Preparation, characterization, molecular docking and bioavailability.
    Zhang JQ; Jiang KM; An K; Ren SH; Xie XG; Jin Y; Lin J
    Carbohydr Res; 2015 Dec; 418():20-28. PubMed ID: 26531135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical applications of cyclodextrins: basic science and product development.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro.
    Hipler UC; Schönfelder U; Hipler C; Elsner P
    J Biomed Mater Res A; 2007 Oct; 83(1):70-9. PubMed ID: 17380497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.
    Brewster ME; Loftsson T
    Pharmazie; 2002 Feb; 57(2):94-101. PubMed ID: 11878196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
    Abdolmaleki A; Ghasemi JB; Ghasemi F
    Curr Drug Targets; 2017; 18(5):556-575. PubMed ID: 26721410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization of vorinostat by cyclodextrins.
    Cai YY; Yap CW; Wang Z; Ho PC; Chan SY; Ng KY; Ge ZG; Lin HS
    J Clin Pharm Ther; 2010 Oct; 35(5):521-6. PubMed ID: 20831676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2011 Sep; 63(9):1119-35. PubMed ID: 21827484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique structure and property of cyclodextrins and their application in transdermal drug delivery.
    Hu J; Tao Z; Cao S
    Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):449-56. PubMed ID: 19907720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.
    Hasan MR; Alsaiari AA; Fakhurji BZ; Molla MHR; Asseri AH; Sumon MAA; Park MN; Ahammad F; Kim B
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions between cyclodextrins and triglycerides: from emulsion stabilisation to the emergence of a new drug delivery system called "beads"].
    Hamoudi M; Trichard L; Grossiord JL; Chaminade P; Duchêne D; Le Bas G; Fattal E; Bochot A
    Ann Pharm Fr; 2009 Nov; 67(6):391-8. PubMed ID: 19900602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers.
    Loftsson T
    Pharmazie; 1998 Nov; 53(11):733-40. PubMed ID: 9853355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
    Buriez O; Heldt JM; Labbé E; Vessières A; Jaouen G; Amatore C
    Chemistry; 2008; 14(27):8195-203. PubMed ID: 18668496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin Inclusion of Medicinal Compounds for Enhancement of their Physicochemical and Biopharmaceutical Properties.
    Caira MR
    Curr Top Med Chem; 2019; 19(25):2357-2370. PubMed ID: 31648636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
    Parrot-Lopez H; Perret F; Bertino-Ghera B
    Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.